Weight Management

 
Shifting Trends in GLP-1RA Prescriptions: Daily Dose
August 13, 2024

Your daily dose of the clinical news you may have missed.

5 Obesity Drugs Worth Watching: 2024-2025
August 13, 2024

Incretin analogues, an oral glucose formulation that targets endogenous nutrient-sensing pathways and a cannabinoid receptor 1 antagonist are in the new mix.

Semaglutide Sold Online without Prescription May Put Users at Risk for Fraud, Overdose
August 05, 2024

Semaglutide bought online without a prescription were unregistered, contaminated, and had levels of product that exceeded labeled amount, according to new data.

Obesity and Type 2 Diabetes: Expert Shares 4 Pillars of Management
August 02, 2024

Caissa Troutman, MD, discusses how clinicians can tailor management plans to reduce risk of developing T2D in patients with obesity.

FDA Warns Clinicians of Adverse Events due to Overdosing of Compounded Semaglutide
July 30, 2024

Lack of dosing experience and errors with converting measurement units may lead to overdosing, the agency reported.

Semaglutide Behind Huge Increase in GLP-RA Prescriptions with Fewer Written for Type 2 Diabetes
July 23, 2024

The significant rise in new GLP-1 RA prescriptions between 2011 and 2023 saw a doubling in the proportion written for obesity and a decline in those for T2D.

Semaglutide vs Tirzepatide for Weight Loss in Persons with Obesity: Daily Dose
July 18, 2024

Your daily dose of the clinical news you may have missed.

Three Obesity-Related Comorbidities and Management Guidance for Primary Care
July 17, 2024

Get details on the relationship between obesity and mental health conditions, chronic pain, and hypertension, here.

Exercise Plus Liraglutide May Preserve Bone Quality during Weight Loss: Daily Dose
July 16, 2024

Your daily dose of the clinical news you may have missed.

Weight Loss with Tirzepatide Significantly Greater than with Semaglutide: New Data
July 08, 2024

Tirzepatide-treated participants were 3 times more likely than those treated with semaglutide to reach weight loss of 15% or greater, the head-to-head study found.